Clinical Trials Arena August 19, 2024
Robert Barrie

While Neuralink has implanted its Telepathy device in two patients, other tech companies are further along in their clinical journey.

Neuralink grabbed much of the ‘brain chip’ headlines earlier this month when the company’s founder and owner Elon Musk announced the second successful implant of its device, but the tech startup is far from the only party that has made advancements in the space.

Brain-computer interfaces (BCIs), also called brain-machine interfaces, are chips implanted in brain tissue that take brain signals and translate them into commands. The signals are then relayed to a secondary, external device, which then carries out a specific function. At present, the main application is in the neuromuscular field, meaning paralysed patients can move muscles just...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Medical Devices, Trends
The capital required for AI-enabled medical devices
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand
Medical Device Makers Seek Exemption From Trump Tariffs
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs

Share This Article